The "SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the SRPX2 gene. This gene has been associated with Rolandic epilepsy, a common form of childhood epilepsy that can interfere with speech and cognitive development. Additionally, mutations in the SRPX2 gene have been linked to mental retardation and speech dyspraxia, a speech disorder that affects a person's ability to correctly pronounce words and sounds. The test, priced at 4400 AED, provides crucial genetic information that can guide treatment options, support early intervention strategies, and help families understand the risk of these conditions being passed on to future generations. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test is a vital tool for families seeking answers to complex neurological and developmental conditions.
The PMP22 Gene Roussy-Levy Syndrome Genetic Test is a specialized diagnostic assessment designed to detect mutations in the PMP22 gene, which are associated with Roussy-Levy Syndrome (RLS). This hereditary condition is characterized by a spectrum of symptoms, including muscle weakness, sensory disturbances, and a decreased ability to coordinate movements, leading to significant challenges in daily activities. The test is a crucial tool for confirming the diagnosis, understanding the condition's progression, and guiding treatment decisions.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the PMP22 gene. This gene plays a critical role in the development and function of peripheral nerves, and mutations can lead to the symptoms observed in Roussy-Levy Syndrome.
The cost of the PMP22 Gene Roussy-Levy Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the advanced technology and expertise required to accurately identify mutations in the PMP22 gene. While the cost may seem significant, the insights provided by the test can be invaluable for affected individuals and their families, offering a clearer understanding of the condition and enabling more effective management strategies.
The RUBCN Gene Salih Ataxia Genetic Test is a specialized diagnostic tool designed to detect mutations in the RUBCN gene, which are implicated in the development of Salih Ataxia, a rare neurodegenerative disorder. This condition is characterized by a progressive loss of coordination and movement, leading to significant physical disability over time. The test is particularly relevant for individuals exhibiting symptoms of ataxia, those with a family history of the condition, or couples considering pregnancy and wishing to assess their risk of passing the condition onto their offspring.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the RUBCN gene that are known to cause Salih Ataxia.
The cost of the RUBCN Gene Salih Ataxia Genetic Test is 4400 AED, reflecting the sophisticated technology and expert analysis involved in its execution. Despite the price, for many patients and families, the test provides invaluable insights into their genetic health, guiding treatment decisions, and offering a clearer understanding of their condition's progression and inheritance pattern.
The MYH7 gene plays a critical role in the body's muscle function, particularly in the heart and skeletal muscles. Mutations in the MYH7 gene can lead to various myopathies, including Scapuloperoneal Myopathy, a rare genetic disorder characterized by progressive weakness and atrophy of the muscles in the shoulders (scapula) and legs (peroneal muscles). This condition can significantly impact an individual's quality of life, making early and accurate diagnosis crucial for managing symptoms and planning treatment strategies.
To diagnose this condition, DNA Labs UAE offers a specialized genetic test that focuses on identifying mutations in the MYH7 gene related to Scapuloperoneal Myopathy. This test is a valuable tool for clinicians and genetic counselors in diagnosing patients with symptoms suggestive of MYH7-related conditions, allowing for a more targeted approach to treatment and management.
The cost of the MYH7-related genetic test at DNA Labs UAE is 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for specific genetic mutations associated with the MYH7 gene. Results from this test can provide crucial information for affected individuals and their families, including the confirmation of a diagnosis, insights into the progression of the disease, and implications for other family members who may be at risk.
Given the specialized nature of this test and its importance in the diagnosis and management of Scapuloperoneal Myopathy, the investment in testing can be a critical step towards achieving a better understanding of the condition and improving patient care.
The CALR gene, known for its role in the endoplasmic reticulum's calcium homeostasis and protein folding, has been a subject of interest in the study of schizophrenia. Research has suggested that mutations or alterations in the CALR gene may contribute to the development of schizophrenia, a complex mental disorder characterized by disruptions in thought processes, perceptions, emotional responsiveness, and social interactions.
DNA Labs UAE offers a specialized genetic test aimed at identifying variations in the CALR gene that may be linked to an increased risk of schizophrenia. This test is a valuable tool for individuals with a family history of schizophrenia or those exhibiting early symptoms of the disorder. By analyzing specific markers within the CALR gene, the test can provide insights into an individual's genetic predisposition to schizophrenia, enabling early intervention and personalized treatment strategies.
The cost of the CALR-related genetic test at DNA Labs UAE is 4400 AED. The test is conducted under the guidance of genetic experts and utilizes advanced genetic sequencing technology to ensure accurate and reliable results. Upon completion, a comprehensive report is provided, detailing the findings and offering recommendations for follow-up care or preventive measures if necessary.
This genetic test represents a significant step forward in the personalized medicine approach to managing schizophrenia, offering hope for better outcomes through targeted interventions based on an individual's genetic makeup.
The CELSR2 gene, located on chromosome 1, has been implicated in various biological processes crucial for normal brain function. Recent studies suggest a potential link between genetic variations in CELSR2 and the development of schizophrenia, a complex psychiatric disorder characterized by disturbances in thought, perception, and behavior. This connection has paved the way for the development of genetic tests aimed at identifying individuals at increased risk based on their CELSR2 gene profile.
DNA Labs UAE offers a specialized genetic test focused on the CELSR2 gene to assess the risk of developing schizophrenia. This test is particularly valuable for individuals with a family history of psychiatric disorders or those exhibiting early symptoms of schizophrenia. By analyzing specific markers within the CELSR2 gene, the test can provide insights into one's genetic predisposition to the disorder.
The cost of the CELSR2-related genetic test at DNA Labs UAE is 4400 AED. The test involves a simple and non-invasive procedure, typically requiring only a saliva or blood sample. Results are usually available within a few weeks and are presented in a comprehensive report. It is important for individuals undergoing this test to consult with healthcare professionals or genetic counselors to fully understand the implications of their results and explore potential preventive or therapeutic strategies.
The GRID2 gene, associated with glutamate receptor signaling pathways, has garnered attention for its potential link to schizophrenia, a complex psychiatric disorder characterized by symptoms such as hallucinations, delusions, and cognitive impairments. Variations or mutations in the GRID2 gene may influence the development or severity of schizophrenia by affecting glutamate signaling, which is crucial for normal brain function and neural communication.
DNA Labs UAE offers a specialized genetic test designed to identify variations in the GRID2 gene that may be related to an increased risk of developing schizophrenia. This test is a valuable tool for individuals with a family history of schizophrenia or those exhibiting early symptoms of the disorder. By understanding one's genetic predisposition, it is possible to take proactive steps in managing the condition, including early intervention and personalized treatment plans.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze genetic material and interpret the results. Conducted in a state-of-the-art laboratory by experienced professionals, the test involves collecting a DNA sample, usually through a simple and non-invasive method such as a cheek swab or blood draw. After the sample is processed and analyzed, a comprehensive report is provided, detailing any detected variations in the GRID2 gene and offering guidance on the implications for schizophrenia risk.
In summary, the GRID2 Related Genetic Test offered by DNA Labs UAE is a cutting-edge diagnostic tool that plays a crucial role in understanding the genetic factors contributing to schizophrenia. With its reasonable cost of 4400 AED, this test represents a significant step forward in personalized medicine, offering individuals valuable insights into their mental health and fostering a proactive approach to managing their well-being.
The NOTCH4 gene, located on chromosome 6, has been implicated in the development of schizophrenia, a complex mental health disorder characterized by symptoms such as hallucinations, delusions, and impaired cognitive functions. Research suggests that variations in the NOTCH4 gene may influence the risk of developing schizophrenia, making it a significant area of study for understanding the genetic underpinnings of this condition.
DNA Labs UAE offers a specialized genetic test focused on the NOTCH4 gene to assess the risk of schizophrenia. This test is designed to detect specific mutations or variations in the NOTCH4 gene that are associated with an increased risk of developing schizophrenia. By analyzing a patient's DNA sample, usually collected through a simple blood draw or cheek swab, the test can provide valuable insights into the individual's genetic predisposition to schizophrenia.
The cost of the NOTCH4 related genetic test at DNA Labs UAE is 4400 AED. This test is a crucial tool for individuals with a family history of schizophrenia or those who exhibit early signs of the disorder, as it can help in early diagnosis and management. Understanding one's genetic risk can also aid in personalized treatment planning, potentially improving outcomes for those affected by schizophrenia.
It's important for individuals considering this test to consult with healthcare professionals or genetic counselors to understand the implications of the results and how they can be integrated into a comprehensive approach to managing or mitigating the risk of schizophrenia.
The HSPG2 Gene Schwartz-Jampel Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the HSPG2 gene, which are associated with Schwartz-Jampel Syndrome Type 1 (SJS1). Schwartz-Jampel Syndrome is a rare genetic disorder characterized by muscle stiffness and abnormalities in bone development, leading to a distinctive facial appearance, among other symptoms. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
This genetic test involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the HSPG2 gene that are indicative of SJS1. The identification of specific gene mutations can confirm a diagnosis, allowing for tailored management and treatment plans for the affected individuals. Moreover, the test can provide essential information for family planning and genetic counseling for families with a history of the syndrome.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results. By opting for this test, individuals suspected of having Schwartz-Jampel Syndrome Type 1, or families with a known history of the condition, can gain valuable insights into their genetic status, aiding in the early detection and management of the syndrome.
The "TH Gene Segawa Syndrome Autosomal Recessive Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the TH gene, which are responsible for Segawa syndrome. Segawa syndrome, also known as Dopa-responsive dystonia (DRD), is a rare genetic disorder characterized by dystonia, tremors, and progressive difficulty in walking. This condition is autosomal recessive, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test specifically targets the TH gene to identify any genetic abnormalities that may lead to the development of Segawa syndrome. Early diagnosis through this genetic testing is crucial for effective management of the syndrome, as it can significantly improve the quality of life of those affected through timely interventions, including pharmacological treatment.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the TH gene. The results from this test can provide valuable information for affected individuals and their families regarding the diagnosis, prognosis, and potential treatment options for Segawa syndrome, facilitating informed decisions about their health care.
